Hibernated Deep Space Travel possible in close future?

Humanity has always been fascinated by deep space travel. From depictions in movies, renders in Artiste s minds, and the absolute marvel of discovering new worlds, the prospects always seem too good to be true. Yet what holds us back is the sheer distance between the stars. While space travel is possible, time is the limit as traveling from the earth. To deal with this, it lies on scientists to either invent faster means of transportation or a deep state of stasis 

Enter Tevosol and ez enRoute, two Edmonton companies that have broken the secret behind human hibernation. This new discovery allows organs donated to be resuscitated from hibernation. While it might not seem a significant achievement, the tech will enable bodies to be placed on stasis to resume a healthy state of operation 

So what’s the big deal about this? The possibilities of these applications are endless, from more prolonged shelf life of donated organs to facilitating deep space travel. The companies’ executives hope to present the discovery to NASA for approval. Should NASA accept their concept, Tevosol and ez enRoute will have a massive win in terms of partnership with the space agency toward research. This partnership might spell out aims to improve and perfect the technology that will be supplied by Tevosol and ez enRoute 

However, they still need to pass the first hurdle that is slamming the three-minute pitch in front of NASA officials and executives. While the pitch will be a high-pressure event in front of judges from the space agency, Tevosol and ez enRoute is privileged to have backing from Aris MD Chandra Devam. She is an iTech alumnus who scored a previous pitch successfully 

The invention is a technological breakthrough that works to put a particular organ set in a set of near body like environment maintaining the said organ in pristine condition. Compared to previous methods that are in current use this holds promise to preserve human tissue for longer in perfect working conditions 

Cryogenic storage methods include the icebox treatment that proves to be inefficient in two standards. One account is that while in cryogenic storage, the organ does not receive the necessary optimal environment and enrichment. The other consideration is that while frozen, donor organs receive a lesser shelf life compared to when in stasis, ensuring that the organ stays fresher for longer. This piece of tech holds high promise for surgery and deep space travel as well. However, it stands on the deciding judges whether this innovation will proceed